AviSia Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $408K

  • Investors
  • 2

AviSia Therapeutics General Information

Description

Developer of antigen-specific immunotherapies intended to treat autoimmune diseases. The company provides immune-modulating therapeutics, primarily focused on type 1 diabetes, enabling patients to have immune tolerance and reduced autoimmune activity while creating lifelong protection against such diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Roetersstraat 35
  • 1018 WB Amsterdam
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Roetersstraat 35
  • 1018 WB Amsterdam
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AviSia Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Sep-2025 $408K Completed Generating Revenue
1. University Spin-Out 01-Jan-2024 Completed Generating Revenue
To view AviSia Therapeutics’s complete valuation and funding history, request access »

AviSia Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AviSia Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovatiefonds Noord-Holland Venture Capital Minority
Amsterdam University Medical Center Corporation
To view AviSia Therapeutics’s complete investors history, request access »

AviSia Therapeutics FAQs

  • When was AviSia Therapeutics founded?

    AviSia Therapeutics was founded in 2024.

  • Where is AviSia Therapeutics headquartered?

    AviSia Therapeutics is headquartered in Amsterdam, Netherlands.

  • What is the size of AviSia Therapeutics?

    AviSia Therapeutics has 4 total employees.

  • What industry is AviSia Therapeutics in?

    AviSia Therapeutics’s primary industry is Drug Discovery.

  • Is AviSia Therapeutics a private or public company?

    AviSia Therapeutics is a Private company.

  • What is AviSia Therapeutics’s current revenue?

    The current revenue for AviSia Therapeutics is .

  • How much funding has AviSia Therapeutics raised over time?

    AviSia Therapeutics has raised $408K.

  • Who are AviSia Therapeutics’s investors?

    Innovatiefonds Noord-Holland and Amsterdam University Medical Center have invested in AviSia Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process